5 completed, 2 recruiting, 1 terminated, 1 unknown. 9 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 5, Recruiting 2, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow creatine monohydrate: new trials by email Literature Review of creatine monohydrate trials Research Report on creatine monohydrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression creatine monohydrate, Placebo, Home-based, telehealth - Metastatic Prostate Cancer | Phase 3 | Recruiting | University of Utah | 200 | 2023-11-09 | 2026-06-03 |
| A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder Creatine monohydrate, Placebo - Major Depressive Disorder | Phase 3 | Completed | University of Utah | 18 | 2020-08-03 | 2024-11-26 |
| Creatine for Depressed Male and Female Methamphetamine Users Creatine monohydrate - Depression, Anxiety | Phase 3 | Recruiting | Montana State University | 29 | 2015-11-01 | 2015-12-11 |
| Effectiveness of Creatine Supplementation and Exercise on Muscle and Bone creatine monohydrate, sugar placebo - Osteoporosis, Sarcopenia | Phase 3 | Completed | University of Saskatchewan | 90 | 2010-01-01 | 2012-12-27 |
| Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Creatine Monohydrate, Placebo - Huntington's Disease | Phase 3 | Terminated | Massachusetts General Hospital | 553 | 2009-09-01 | 2016-03-11 |
| Creatine in Treating Patients With Cancer-Associated Weight Loss creatine monohydrate, placebo - Anorexia, Cachexia | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 300 | 2004-12-01 | 2020-04-29 |
| Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis Creatine Monohydrate - Amyotrophic Lateral Sclerosis (ALS) | Phase 3 | Unknown | The Avicena Group | 107 | 2003-06-01 | 2005-06-24 |
| Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy Creatine Monohydrate, Glutamine - Muscular Dystrophy, Duchenne | Phase 2 / Phase 3 | Completed | Cooperative International Neuromuscular Research Group | 48 | 2000-06-01 | 2011-10-27 |
| A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD) glutamine, creatine monohydrate - Muscular Dystrophy, Duchenne | Phase 3 | Completed | National Center for Research Resources (NCRR) | 2005-06-24 |
Muscular Dystrophy, Duchenne (2) · Amyotrophic Lateral Sclerosis (1) · Anorexia (1) · Anxiety Disorders (1) · Body Weight Changes (1) · Cachexia (1) · Depression (1) · Depressive Disorder, Major (1) · Huntington Disease (1) · Mitochondrial Diseases (1) · Osteoporosis (1) · Prostatic Neoplasms (1) · Sarcopenia (1)
University of Utah (2) · Alliance for Clinical Trials in Oncology (1) · Cooperative International Neuromuscular Research Group (1) · Massachusetts General Hospital (1) · Montana State University (1) · National Center for Research Resources (NCRR) (1) · The Avicena Group (1) · University of Saskatchewan (1)
United States (8) · Canada (2) · Australia (1) · New Zealand (1)
Adriana Coletta, PhD, MS, RD (1) · Aminah Jatoi, MD (1) · Darren Candow, Ph.D. (1) · Diana M Escolar, MD (1) · Diana Rosas, MD, MS (1) · Giovanni Schifitto, MD (1) · Gunnar Buyse, MD, PhD (1) · Philip Chilibeck, Ph.D. (1) · Rosenfeld Jeffrey, MD (1) · Steven M Hersch, MD, PhD (1) · Tracy Hellem, PhD (1)
PMID 15984021, PMID 28701493, PMID 30103342, PMID 34107512, PMID 35747889, PMID 38637770
R01CA281759 (1), U01AT000613 (1)